Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion

Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion

Purpose: Intravenous immune globulin (IVIG) therapy is used in patients with hypogammaglobulinemia to lower the risk of infections. IVIG and subcutaneous IVIG (SCIG) therapy have been to shown to be safe and effective when administered as clinic-based infusions. Concern from both patients and provid...

Full description

Bibliographic Details
Main Authors: Abdelghany, O. (Author), Barbarotta, L. (Author), Bocchetta, N. (Author), Clinchy-Jarmoszko, V. (Author), Foss, F. (Author), Huntington, S. (Author), Isufi, I. (Author), Perreault, S. (Author), Schiffer, M. (Author), Seropian, S. (Author)
Format: Article
Language:English
Published: Oxford University Press 2021
Subjects:
adult
Adult
aged
Aged
Aged, 80 and over
Ambulatory Care Facilities
antiphospholipid syndrome
Article
clinical article
controlled study
coronavirus disease 2019
cost benefit analysis
cost control
COVID-19
disease transmission
economics
female
Female
follow up
high risk patient
home care
Home Care Services
home infusion therapy
human
human immunoglobulin
Humans
Immunocompromised Host
immunocompromised patient
immunoglobulin
immunoglobulin deficiency
Immunoglobulins, Intravenous
immunosuppressed population
infection prevention
intravenous immune globulin
male
Male
middle aged
Middle Aged
organization and management
outpatient department
patient care
Patient Care Team
patient satisfaction
Patient Satisfaction
prevention and control
questionnaire
reimbursement
risk assessment
risk management
risk reduction
SARS-CoV-2
subcutaneous immune globulin
United States
very elderly
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items